Verona Pharma plc (VRNA) Free Cash Flow by Year
Verona Pharma plc recorded an outflow of $122.8M in free cash flow in fiscal year 2024. This represents a decrease of 144.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to an outflow of $73.6M in free cash flow. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Verona Pharma plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VRNA Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
VRNA Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Verona Pharma plc financials
Frequently Asked Questions
What was Verona Pharma plc's free cash flow in fiscal year 2024?
Verona Pharma plc recorded an outflow of $122.8M in free cash flow in fiscal year 2024.
How fast is Verona Pharma plc's free cash flow growing?
Verona Pharma plc (VRNA) free cash flow fell by 144.5% year over year, from -$50.2M to -$122.8M in fiscal year 2024.
What is Verona Pharma plc's free cash flow over the last twelve months?
Verona Pharma plc (VRNA) reported an outflow of $73.6M in free cash flow over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
How has Verona Pharma plc's free cash flow changed over the years?
Across the 6 fiscal years this page covers, Verona Pharma plc (VRNA) free cash flow went from -$42.9M in fiscal year 2019 to -$122.8M in fiscal year 2024.
What was Verona Pharma plc's free cash flow in the most recent quarter?
Verona Pharma plc (VRNA) reported $30.6M in free cash flow in Q2 2025. This represents an increase of 278.4% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Verona Pharma plc (VRNA) reported on that line in every period on record.